Unique mono-test immunoreaction cartridge for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of β-amyloid1-40 in human cerebrospinal fluid.
The Lumipulse G β-Amyloid 1-40 assay is intended to be used in conjunction with Lumipulse G β-Amyloid 1-42 assay to determine the amyloid ratio (β-amyloid1-42 / β-amyloid1-40 ratio) in the clinical setting of dementia diagnosis. This CSF amyloid ratio (β-amyloid1-42 / β-amyloid1-40 ratio) is intended to be used as an aid for diagnosis in patients with cognitive impairment who are being evaluated for Alzheimer's Disease (AD) and other causes of cognitive decline. The CSF amyloid ratio supports the probability of AD pathology only as an adjunct to other diagnostic evaluations.
Lumipulse G β-Amyloid 1-40 Immunoreaction Cartridges (IRC):
Art. no. 231524 (3 x 14 Tests - CE) - Please contact your local Fujirebio representative for the availability of this product in your country.
Lumipulse G β-Amyloid 1-40 Calibrators set:
- Art. no. 231531 (2 x 3 concentrations - CE) - Please contact your local Fujirebio representative for the availability of this product in your country.
See the LUMIPULSE G1200 working in this video:
These resources are either available in free access or for users holding a Premium eServices account: